# ORTHOCON INC: Form D filing

ORTHOCON INC, a biotechnology company in North Brunswick, NJ, filed a Form D with the SEC in 2009. The latest, on April 10, 2009, reports $10.5 million sold of a $25 million offering to 8 investors.

Find out what ORTHOCON INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20ORTHOCON%20INC%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=ORTHOCON%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Forthocon-inc-1446928)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20ORTHOCON%20INC%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=ORTHOCON%20INC&page=%2Fdata%2Fform-d%2Fcompany%2Forthocon-inc-1446928)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey): 714 rows, by operating companies, filed since November 1, 2024, $35.70, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/new-jersey
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 675 US Highway One, North Brunswick, NJ, 08902
- Phone: (732) 418-0025
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: De
- Year incorporated: 2005
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1446928

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 10, 2009 | New notice | $24,999,937 | $10,499,949 | $14,499,988 | 8 | Mar 19, 2009 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1446928/000144692809000002/0001446928-09-000002-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Alan Levy, Ph.D | Director |  |
| John Pacifico | Executive Officer |  |
| Paul Sohmer, M.D. | Executive Officer, Director |  |
| Seth Rudnick, M.D. | Director |  |
| David Knaack | Executive Officer |  |
| Klaus Breiner, Ph.D | Director |  |
| Richard Kronenthal, Ph.D | Executive Officer |  |
| Joyce Tsang, Ph.D | Director |  |

## Other biotechnology companies in New Jersey that filed recently

- [Ensho Therapeutics, Inc.](https://specstream.ai/data/form-d/company/ensho-therapeutics-inc-2032849) $7.3 million · Oct 15, 2026
- [Xenon Ophthalmics Inc](https://specstream.ai/data/form-d/company/xenon-ophthalmics-inc-1988832) $3.3 million · Oct 6, 2026
- [LISATA THERAPEUTICS, INC.](https://specstream.ai/data/form-d/company/lisata-therapeutics-inc-320017) $351.9 million · Oct 2, 2026

[Every Form D from the week of Apr 6, 2009](https://specstream.ai/data/form-d/week/2009-04-06) · [All recent filings in New Jersey](https://specstream.ai/data/form-d/state/new-jersey) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what ORTHOCON INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).